Annual Drug Patent Expirations for CLARINEX+D+24+HOUR Clarinex D 24 Hour is a drug marketed by Merck Sharp Dohme and is included in one NDA. There are two patents protecting this…
The post New patent expiration for Merck Sharp drug CLARINEX D 24 HOUR a…
New patent expiration for Merck Sharp drug CLARINEX D 24 HOUR Read Post »
Annual Drug Patent Expirations for TRULANCE Trulance is a drug marketed by Salix and is included in one NDA. It is available from two suppliers. There are nine patents protecting…
The post New patent expiration for SALIX drug TRULANCE appeared first on…
This chart shows the pharmaceutical companies with the most patents in United Kingdom. Patents must be filed in each country (or, in some cases regional patent office) where patent protection…
The post Which pharmaceutical companies have the most drug …
Which pharmaceutical companies have the most drug patents in United Kingdom? Read Post »
Annual Drug Patent Expirations for RECORLEV Recorlev is a drug marketed by Strongbridge and is included in one NDA. There are five patents protecting this drug. This drug has twenty-seven…
The post New patent for Strongbridge drug RECORLEV appeared fir…
Annual Drug Patent Expirations for QINLOCK Qinlock is a drug marketed by Deciphera Pharms and is included in one NDA. There are five patents protecting this drug. This drug has…
The post New patent for Deciphera Pharms drug QINLOCK appeared first on Dr…
Annual Drug Patent Expirations for FINTEPLA Fintepla is a drug marketed by Zogenix Inc and is included in one NDA. It is available from one supplier. There are eleven patents…
The post New patent for Zogenix Inc drug FINTEPLA appeared first on DrugPate…
This chart shows the drugs with the most supplementary protection certificates (SPCs). SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the long…
The post Which drugs have supplementary protec…
Which drugs have supplementary protection certificates in the most countries? Read Post »
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Romania. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical…
Which pharmaceutical companies have the most SPCs in Romania? Read Post »
Annual Drug Patent Expirations for ROZLYTREK Rozlytrek is a drug marketed by Genentech Inc and is included in one NDA. It is available from one supplier. There are thirteen patents…
The post New patent for Genentech Inc drug ROZLYTREK appeared first on…
Annual Drug Patent Expirations for GAVRETO Gavreto is a drug marketed by Genentech Inc and is included in one NDA. It is available from one supplier. There is one patent…
The post New patent for Genentech Inc drug GAVRETO appeared first on DrugPatentWa…
Get new actionable insights and updates from BiotechBlog
